6.400
−5,88%
2026-10-14
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -37.6% | -29.8% | 0 / 3 | -8.4% | +0.08 pp | -0.42 pp | +4.0% | 2.01 | 12.17 | 1.159 | −8,4% | 10,3 | −38,0% | 12.17 | 14.76 | −17,5% |
| Pts | 0 | 0 | 0 | 0 | 8 | 4 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 6.400 (close price on 2026-10-14)EPS (TTM): 525,8
Financial charts
1.Revenue & growth
VND bn1.159Q2/26
1.Revenue & growth
VND bn1.159Q2/26
2.Profit & growth
VND bn10,2Q2/26
3.Profit mix (Penman)
VND bn42,2Q2/26
4.Margins & cost structure
%4.8%Q2/26
5.Returns & cash cycle
% · days6.6%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn3.957Q2/26
8.Funding & debt health
VND bn · times3.957Q2/26
9.Revenue backlog
VND bn471Q2/26
10.Valuation
times · %12,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %157Q2/26
Adjusted EPS growth, latest quarter
-37.6%
Average adjusted EPS growth, 3 quarters
-29.8%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26